On Tuesday, October 23rd, the European Society for Medical Oncology Congress (ESMO) ended its annual Congress in Munich with over 26,000 oncology professionals from all over the world. This congress was a perfect place to present our main services to different global pharmaceutical and biotechnological companies as well as investigators or other oncologists and this was well received by all of them.

Pivotal, presented its services at booth 244 where it succeeded in establishing important links and contacts in the pharmaceutical and biotechnology area. The main goal was to attract new clients both in the short and long term as well as meet our current ones who attended the event.

ESMO 2019 annual congress will take place in Barcelona, from the 27th of September to 1st October.

ABOUT PIVOTAL

Founded in 2001, Pivotal is a leading full-services CRO offering services to the healthcare industry across Europe. We take on the immense challenges for supporting cutting-edge clinical development programmes with IMPs, medical devices, diagnostics and nutrition products. Our clients enjoy the benefits of senior management hands-on environment, operational teams working on the ground with the clinical sites, deep therapeutic expertise and cost-effective deliverables. We share our clients objectives and deliver a solid programme to achieve promising results.

Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

New evidence found of the neurotoxic eff...

by Universitat Rovira i Virgili

URV researchers are taking part in a pioneering study that analyses th...

Photos Stream